PTLF (Petlife Pharmaceuticals) Beginning Cash Position: $0.05 Mil (As of Feb. 2018)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Petlife Pharmaceuticals Beginning Cash Position?

Petlife Pharmaceuticals PTLF Beginning Cash Position is $0.05 Mil as of Feb. 2018.

Petlife Pharmaceuticals's Beginning Cash Position for the quarter that ended in Feb. 2018 was $0.05 Mil.

Petlife Pharmaceuticals's quarterly Beginning Cash Position increased from Aug. 2017 ($-0.05 Mil) to Nov. 2017 ($0.05 Mil) but then stayed the same from Nov. 2017 ($0.05 Mil) to Feb. 2018 ($0.05 Mil).

Petlife Pharmaceuticals's annual Beginning Cash Position declined from Aug. 2015 ($0.01 Mil) to Aug. 2016 ($-0.00 Mil) but then increased from Aug. 2016 ($-0.00 Mil) to Aug. 2017 ($0.00 Mil).

Petlife Pharmaceuticals Beginning Cash Position Related Terms

Petlife Pharmaceuticals Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Petlife Pharmaceuticals's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Petlife Pharmaceuticals Beginning Cash Position Chart

Petlife Pharmaceuticals Annual Data
Trend Aug08 Aug09 Aug10 Aug11 Aug12 Aug13 Aug14 Aug15 Aug16 Aug17
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.00 0.01 -0.00 0.00

Petlife Pharmaceuticals Quarterly Data
May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.00 -0.05 0.05 0.05

Petlife Pharmaceuticals Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $0.05 Mil mean?
Petlife Pharmaceuticals (PTLF) has a Beginning Cash Position of $0.05 Mil as of Feb. 2018. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Petlife Pharmaceuticals and its competitors.
Is Petlife Pharmaceuticals' Beginning Cash Position too high?
Petlife Pharmaceuticals' current Beginning Cash Position is $0.05 Mil.
How does Petlife Pharmaceuticals' Beginning Cash Position compare to PCYN and YBAO?
Petlife Pharmaceuticals' Beginning Cash Position of $0.05 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Drug Manufacturers company?
A good Beginning Cash Position depends on the Drug Manufacturers industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Petlife Pharmaceuticals and its competitors. Petlife Pharmaceuticals's current Beginning Cash Position is $0.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Petlife Pharmaceuticals stock overvalued right now?
Petlife Pharmaceuticals (PTLF) has a current Beginning Cash Position of $0.05 Mil. The current Beginning Cash Position is $0.05 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Petlife Pharmaceuticals (PTLF), the current Beginning Cash Position is $0.05 Mil as of Feb. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Petlife Pharmaceuticals Business Description

Address 38 West Main Street, 6th Floor, Hancock, MD, USA, 21750
Petlife Pharmaceuticals Inc specializes in the research, development, sales, and support of advanced drugs and nutraceuticals for pet cancer and autoimmune related diseases such as arthritis. It develops potentiated veterinary cancer medications and nutraceuticals, under its tradename Vitalzul based on Escozine formula. The Vitalzul is a polarized, bioactive peptide extracted from the Blue Caribbean Scorpion (Rhopularus Princeps), which contains amino acids, proteins, and minerals.